TELA Bio (TELA) Gross Profit (2018 - 2026)

TELA Bio's Gross Profit history runs 9 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• On a quarterly basis, Gross Profit changed 0.06% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $54.3 million, a 14.03% increase from a year earlier, with the FY2025 full-year figure at $54.3 million, up 16.89% from the prior year.
• Gross Profit eased to $12.5 million in Q1 2026 per TELA's latest filing, from $13.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $14.1 million in Q2 2025 and bottomed at $5.0 million in Q1 2022.
• The 5-year median for Gross Profit is $11.2 million (2024), against an average of $10.6 million.
• Across the five-year window, Gross Profit jumped 59.04% in 2022 and fell 3.47% in 2024, its largest moves.
• Year by year, Gross Profit stood at $8.2 million in 2022, then jumped by 42.17% to $11.6 million in 2023, then slipped by 3.47% to $11.2 million in 2024, then increased by 22.58% to $13.8 million in 2025, then declined by 8.98% to $12.5 million in 2026.
• Per Business Quant, the three latest TELA Gross Profit figures stand at $12.5 million (Q1 2026), $13.8 million (Q4 2025), and $14.0 million (Q3 2025).